|Bid||32.10 x 800|
|Ask||34.59 x 1000|
|Day's Range||34.08 - 34.62|
|52 Week Range||21.98 - 35.54|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||43.72%|
|Beta (3Y Monthly)||1.97|
|Expense Ratio (net)||0.75%|
The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.
The release of encouraging data on the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders puts emphasis on some genomic ETFs.
For anyone not familiar with ARK Invest, they have a suite of ETF strategies dedicated to helping investors hone in on disruptive innovations and technologies with the potential to affect the global economy.
For anyone not familiar with ARK Invest, they have a suite of ETF strategies dedicated to helping investors hone in on disruptive innovations and technologies with the potential to affect the global economy. ...
There are new developments in DNA sequencing that are making a huge impact on healthcare and the direction of growth in the industry. To take advantage of this opportunity, investors can look to a targeted ETF strategy to gain exposure to this next generation of DNA sequencing. In the recent webcast, Next Generation DNA Sequencing: An Investor Field Guide, Simon Barnett, Analyst, Genomic Revolution, ARK Invest; and Tom Staudt, Chief Operating Officer, ARK Invest, sought to to size the potential investment opportunity in innovative technologies, notably those in the healthcare industry and DNA sequencing.
Next generation DNA sequencing could set the stage for a new era in medicine given its accuracy, cost-effectiveness, and soon—affordability. In the upcoming webcast, Next Generation DNA Sequencing: An ...
As ETFs mature and the appeal of their structure becomes more accepted, fund managers will increasingly opt to use an ETF framework, rather than a mutual fund, as the backbone for their investing strategies.
Kevin Cook joins us to help walk us through the maze that is the healthcare industry. We touch on everything from the hottest trends all the way down to how to pick a winning stock!
ETF investors who want to diversify into new areas of potential growth should identify areas of innovation and look to technologies that are disrupting the markets. On the recent webcast, Focusing on Disruptive ...
While uncertainties may affect the various market segments in the short run, the long-term trends reveal a global economy that is quickly advancing technologies that can disrupt markets and provide further ...
UK Biobank, an international health resource and charity, is leading the charge in what is the world’s largest genetics project, which should put the ARK Genomic Revolution Multi-Sector ETF (ARKG ) on watch for investors.
UK Biobank, an international health resource and charity, is leading the charge in what is the world’s largest genetics project, which should put the ARK Genomic Revolution Multi-Sector ETF (ARKG) on watch for investors. Per a Technology Networks report, “The biobank recruited 500,000 volunteers aged between 40–69 years from across the country and collected a variety of biological measures and data from them, including blood, urine and saliva samples. The primary goal of the project is to collect data in order to best determine the pathophysiology and heterogeneity of human diseases.
Rising investments and growing technological advancement are favoring the genomic editing space. We take a look at a few ETFs that can cash in on this trend.
Rising investments, surging demand for personalized medicines and shrinking sequencing costs are a slew of factors favouring the genomics space. We look at a few ETFs that can cash in on this trend.
Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.
These ETFs focus exclusively on U.S. equities and deserve the attention of investors seeking a domestic tilt to their portfolio ahead of the Jul 4 holiday.
With just a trading session left to end the first half, the Dow Jones is up about 13.7% while the S&P 500 and Nasdaq have gained 16.7% and 20.1%, respectively.
New disruptive technologies are changing the way we interact with the world, providing growth opportunities for exchange traded fund investors whom are looking to diversify into these quickly developing segments.